About GBT

GBT is a biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. The company has one FDA-approved therapy for sickle cell disease and one investigational therapy in development for the disease.

more »

Innovative Science

We are passionate and committed to developing new therapies that can provide transformative clinical benefit to patients.

more »